FDA Approves Daxxify, a New Anti-Wrinkle Drug
The treatment lasts for six months in half of its users, company studies showed, representing the first major advance in facial injections in decades.
Call for more information
  888-531-0245
  info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.